Table 7.
Groups | Blood (µg/ml) | Liver (µg/g tissue) | Kidney (µg/g tissue) | Brain (µg/g tissue) |
---|---|---|---|---|
Control group | 0.15±0.011 | 0.68±0.13 | 0.12±0.01 | ND |
Cd exposed group | 11.79±2.4*** | 16.87±1.17*** | 13.49±2.21*** | 3.89±0.27 |
Ceftriaxone plus sulbactam with VRP1034 treated group | 6.75±0.89*** | 10.11±0.83*** | 9.55±1.07*** | 0.62±0.12*** |
All data are Mean ± SD of each group. Newman-Keuls test was performed for statistical significance between control group vs Cd exposed group and Cd exposed group vs ceftriaxone plus sulbactam with VRP1034 treated group.
Where p<0.001 (highly significant)
p<0.01(significant)
p<0.05 (significant)
p>0.05 (non significant).